Feed Preview

Charcot-Marie-Tooth Disease (CMT)

Charcot-Marie-Tooth Disease (CMT) diagram by Nephron, Wikimedia
Nephron, Wikimedia

Charcot-Marie-Tooth (CMT) disease is a hereditary motor and sensory neuropathy characterized by loss of muscle and touch sensation. Discover the latest research on CMT here.

Top 20 most recent papers
Clinical Endocrinology

Diagnosis and management of central diabetes insipidus in adults

Clinical EndocrinologyOctober 1, 2018
Aoife GarrahyChristopher J Thompson
33
29
Gait & Posture

Evaluation of muscle strength, balance and functionality of individuals with type 2 Charcot-Marie-Tooth Disease

Gait & PostureApril 21, 2018
Iandra Maria Pinheiro de França CostaAdriano Antunes de Souza Araújo
Oral Health & Preventive Dentistry

Impact of Health Locus of Control on Oral Health Status among a Cohort of IT Professionals

Oral Health & Preventive DentistryJuly 22, 2018
Pilla PadmajaK Sahithi Reddy
Acta dermatovenerologica Croatica : ADC

Drug-induced Subacute Cutaneous Lupus Erythematosus Caused by a Topical Beta Blocker - Timolol

Acta dermatovenerologica Croatica : ADCMay 22, 2018
Monika Bilewicz-StebelAnna Stańkowska
Pituitary

Posterior pituitary dysfunction following traumatic brain injury: review

PituitaryOctober 19, 2018
Roxana Maria Tudor, Christopher J Thompson
1
1
23
Molecular Genetics & Genomic Medicine

A novel GJB1 mutation associated with X-linked Charcot-Marie-Tooth disease in a large Chinese family pedigree

Molecular Genetics & Genomic MedicineJanuary 17, 2020
Yingdi LiuLingqian Wu
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia

Expansion of the phenotypic spectrum of X-linked Charcot-Marie-Tooth (CMT) disease

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of AustralasiaJanuary 29, 2020
Qijie YangJuan Du
1
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia

Systemic lupus erythematosus with Sjögren's syndrome and renal tubular acidosis presenting as nephrogenic diabetes insipidus

Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi ArabiaApril 17, 2018
Ashaq Hussain ParreyAdil Basher
Brain : a Journal of Neurology

Stop-gain mutations in UBAP1 cause pure autosomal-dominant spastic paraplegia

Brain : a Journal of NeurologyJune 17, 2019
Xiang LinWan-Jin Chen
11
1
6
Journal of Human Genetics

An estimation of the prevalence of genomic disorders using chromosomal microarray data

Journal of Human GeneticsApril 25, 2018
Madelyn A GillentineChristian P Schaaf
19
3
34
Frontiers in Molecular Neuroscience

Differential Expression of Several miRNAs and the Host Genes AATK and DNM2 in Leukocytes of Sporadic ALS Patients

Frontiers in Molecular NeuroscienceApril 20, 2018
Katarina VrabecMetka Ravnik-Glavač
2
22

See more papers from this feed

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/charcot-marie-tooth-disease-cmt/5af96694-9337-4497-b36c-891062af3616